
Varivax0.5 ml
Healthcare Pharmaceuticals Ltd.
Established / Approved Use Varicella Virus Vaccine is indicated for active immunization for the prevention of varicella (chickenpox) in healthy individuals 12 months of age and older who have no…
Varicella Virus Vaccine is indicated for active immunization for the prevention of varicella (chickenpox) in healthy individuals 12 months of age and older who have no history of the disease and no evidence of immunity.
Varicella Virus Vaccine is not intended for treatment of active varicella or herpes zoster infection.
| Population | Dose / Schedule |
|---|---|
| Children 12 months - 12 years | Two 0.5 mL doses of Varicella Virus Vaccine: first dose at 12-15 months of age, second dose at 4-6 years (may be given earlier if at least 3 months after the first dose, per local schedule). |
| Adolescents ≥13 years and adults (susceptible, no immunity) | Two 0.5 mL doses of Varicella Virus Vaccine given 4-8 weeks apart. |
| Post-exposure prophylaxis | A single 0.5 mL dose of Varicella Virus Vaccine, ideally within 3-5 days of exposure, following the standard age-appropriate schedule for any subsequent dose(s). |
Varicella Virus Vaccine is administered only by subcutaneous injection; see Administration and Reconstitution for preparation and injection technique.
Most reactions to Varicella Virus Vaccine are mild and self-limited.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.